Previous 10 | Next 10 |
Restructured Venture Also Seeks Licensing Partners for ABVC Fremont, CA - ( NewMediaWire ) - October 12, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced ...
Gainers: Grom Social Enterprises (NASDAQ:GROM) +181%. Paltalk (NASDAQ:PALT) +123%. Camber Energy (NYSE:CEI) +34%. Smart Share Global (NASDAQ:EM) +32%. Neonode (NASDAQ:NEON) +27%. EZFill Holdings (NASDAQ:EZFL) +21%. NuCana NCNA +19%. Regencell Bioscience Holdings (NASDAQ:RGC) +17%. Greeni...
Completion of the Study Expected by the End of 2022 Fremont, CA - ( NewMediaWire ) - September 13, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it has...
Assembly Biosciences ASMB -19% after abandons development of phase 2 hepatitis b candidate ABVC BioPharma (NASDAQ:ABVC) -12%. Chewy CHWY -10% on Q2 earnings release American Eagle Outfitters AEO -9% on Q2 earnings release Five Below FIVE -8% on Q2 earni...
Gainers: Sequential Brands Group (NASDAQ:SQBG) +49%. Rockley (NYSE:RKLY) +27%. Aterian (NASDAQ:ATER) +24%. Ambarella (NASDAQ:AMBA) +24%. Washington Prime Group (NYSE:WPG) +22%. Vinco Ventures (NASDAQ:BBIG) +20%. Evaxion Biotech (NASDAQ:EVAX) +20%. Standard Lithium (NYSE:SLI) +18%. ABVC BioPha...
Gainers: ABVC BioPharma (NASDAQ:ABVC) +32%, Bellicum Pharmaceuticals (NASDAQ:BLCM) +22%, Evaxion Biotech (NASDAQ:EVAX) +22%, GBS (NASDAQ:GBS) +22%, PetVivo (NASDAQ:PETV) +17%. Losers: Avidity Biosciences (NASDAQ:RNA) -18%, So-Young (...
Fremont, CA - ( NewMediaWire ) - September 01, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it has filed new PCT (Patent Cooperation Treaty) applications i...
Fremont, CA - ( NewMediaWire ) - August 30, 2021 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Zacks Small Cap Research has issued an update report on the...
Gainers: Glory Star New Media Group Holdings (NASDAQ:GSMG) +41%. SGOCO (NASDAQ:SGOC) +35%. Ascendis Pharma A/S (NASDAQ:ASND) +22%. Zomedica (NYSE:ZOM) +18%. Dolphin Entertainment (NASDAQ:DLPN) +17%. Jowell Global (NASDAQ:JWEL) +18%. Lordstown Motors (NASDAQ:RIDE) +17%. ABVC BioPharma (OTCQB:A...
Gainers: Ascendis Pharma (NASDAQ:ASND) +25%, Zomedica (NYSE:ZOM) +15%, ABVC BioPharma (OTCQB:ABVC) +15%, BeyondSpring (NASDAQ:BYSI) +13%, Cortexyme (NASDAQ:CRTX) +12%. Losers: Aditxt (NASDAQ:ADTX) -29%, Quanterix (NASDAQ:QTRX) -12%, Doxim...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc. and AiBtl BioPharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will i...
FREMONT, CA - ( NewMediaWire ) - July 9, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, announced today that after successful Phase II c...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...